Fear memory consolidation in sleep requires protein kinase A.
Level 5 - mechanism / opinion, no new human data
Animal laboratory experiment
PubMed 29661836 · doi:10.1101/lm.046458.117
What was done
Animals were trained on contextual fear conditioning and categorized into sleep or awake groups based on behavioral observation. Researchers administered intrahippocampal microinjections of either the protein kinase A (PKA) inhibitor Rp-cAMPs during post-conditioning sleep or awake states, or the PKA activator Sp-cAMPs in an awake state following sleep deprivation, to assess effects on long-term fear memory consolidation.
What was found
The abstract reports no numerical values, sample sizes, or effect sizes. Directionally, intrahippocampal injection of Rp-cAMPs during post-conditioning sleep suppressed long-term fear memory, whereas the same injection during the awake state at an equivalent time point had no effect. Conversely, administration of the PKA activator Sp-cAMPs during wakefulness rescued memory impairment induced by sleep deprivation.
Why it matters
The findings demonstrate a state-specific role for hippocampal PKA signaling, indicating that PKA activation during sleep is mechanistically necessary for consolidating long-term fear memories.
Limits
The study was conducted in an animal model, limiting direct translation to human physiology. The abstract does not specify the animal species, sample sizes, exact timing or dosages of pharmacological agents, or quantitative measures and statistical certainty.
Cited by
- supports Blocking protein kinase A (PKA) prevents the long-term consolidation and transfer of hippocampal memories to cortical areas during sleep.